| Low-dose methotrexate for the prevention of atherosclerotic events PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ... New England Journal of Medicine 380 (8), 752-762, 2019 | 1126 | 2019 |
| Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian … D Waters, L Higginson, P Gladstone, B Kimball, M Le May, SJ Boccuzzi, ... Circulation 89 (3), 959-968, 1994 | 695 | 1994 |
| A citywide protocol for primary PCI in ST-segment elevation myocardial infarction MR Le May, DY So, R Dionne, CA Glover, MPV Froeschl, GA Wells, ... New England Journal of Medicine 358 (3), 231-240, 2008 | 530 | 2008 |
| Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial JD Roberts, GA Wells, MR Le May, M Labinaz, C Glover, M Froeschl, ... The Lancet 379 (9827), 1705-1711, 2012 | 463 | 2012 |
| Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) MR Le May, GA Wells, M Labinaz, RF Davies, M Turek, D Leddy, ... Journal of the American College of Cardiology 46 (3), 417-424, 2005 | 383 | 2005 |
| Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis F Borgia, SG Goodman, S Halvorsen, WJ Cantor, F Piscione, MR Le May, ... European heart journal 31 (17), 2156-2169, 2010 | 276 | 2010 |
| Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial A Kulik, MR Le May, P Voisine, JC Tardif, R DeLarochelliere, S Naidoo, ... Circulation 122 (25), 2680-2687, 2010 | 231 | 2010 |
| Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy JP Collet, G Montalescot, M Le May, M Borentain, A Gershlick Journal of the American College of Cardiology 48 (7), 1326-1335, 2006 | 216 | 2006 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 200 | 2019 |
| Milrinone as compared with dobutamine in the treatment of cardiogenic shock R Mathew, P Di Santo, RG Jung, JA Marbach, J Hutson, T Simard, ... New England Journal of Medicine 385 (6), 516-525, 2021 | 164 | 2021 |
| Stenting versus thrombolysis in acute myocardial infarction trial (STAT) MR Le May, M Labinaz, RF Davies, JF Marquis, LA Laramée, ER O’Brien, ... Journal of the American College of Cardiology 37 (4), 985-991, 2001 | 160 | 2001 |
| 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology guidelines on the acute management of ST-elevation myocardial infarction: focused update … GC Wong, M Welsford, C Ainsworth, W Abuzeid, CB Fordyce, J Greene, ... Canadian Journal of Cardiology 35 (2), 107-132, 2019 | 156 | 2019 |
| Comparison of early mortality of paramedic-diagnosed ST-segment elevation myocardial infarction with immediate transport to a designated primary percutaneous coronary … MR Le May, RF Davies, R Dionne, J Maloney, J Trickett, D So, A Ha, ... The American journal of cardiology 98 (10), 1329-1333, 2006 | 136 | 2006 |
| Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention SC Goncalves, M Labinaz, M Le May, C Glover, M Froeschl, JF Marquis, ... The American journal of cardiology 107 (2), 204-209, 2011 | 132 | 2011 |
| Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial A Kulik, P Voisine, P Mathieu, RG Masters, TG Mesana, MR Le May, ... The Annals of thoracic surgery 92 (4), 1284-1291, 2011 | 117 | 2011 |
| Transradial versus transfemoral artery approach for coronary angiography and percutaneous coronary intervention in the extremely obese B Hibbert, T Simard, KR Wilson, S Hawken, GA Wells, FD Ramirez, ... JACC: Cardiovascular Interventions 5 (8), 819-826, 2012 | 113 | 2012 |
| Safety and efficacy of femoral access vs radial access in ST-segment elevation myocardial infarction: the SAFARI-STEMI randomized clinical trial M Le May, G Wells, D So, AY Chong, A Dick, M Froeschl, C Glover, ... JAMA cardiology 5 (2), 126-134, 2020 | 107 | 2020 |
| Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety … AB Greenbaum, EM Ohman, CM Gibson, S Borzak, AL Stebbins, M Lu, ... American Heart Journal 154 (4), 702-709, 2007 | 105 | 2007 |
| Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention MR Le May, GA Wells, DY So, CA Glover, M Froeschl, J Maloney, ... Journal of the American College of Cardiology 60 (14), 1223-1230, 2012 | 87 | 2012 |
| Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, ... The Lancet 392 (10161), 2269-2279, 2018 | 86 | 2018 |
